SCHEMBL3079374

SCHEMBL3079374

C=CC1(CC(N)=O)CC(C)(C)CC(C)(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3079293 0.82 PTGS1 (0.31)
SCHEMBL8336653 0.71
SCHEMBL6659485 0.69 GRIN2D (0.31)
SCHEMBL7002732 0.65
SCHEMBL7545353 0.63 PKM (0.30)
SCHEMBL17586295 0.61 PKM (0.46)
SCHEMBL3654075 0.61 ALDH1A1 (0.35)
SCHEMBL8787565 0.61
SCHEMBL6664271 0.60
SCHEMBL5145929 0.60 PKM (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105106981-B Dianthranide quinones application in preparation of anti-tumor drugs 江苏省中医药研究院 2018-12-28 CN claimed
US-20210169864-A1 COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS MERZ PHARMA GMBH & CO KGAA (DE) 2021-06-10 US disclosed
CN-109563028-A The method for preparing isocyanates and other at least one chemical products in production association 科思创德国股份有限公司 2019-04-02 CN disclosed
CN-109310668-A Positive allosteric modulators of muscarinic acetylcholine receptor M4 范德比尔特大学 2019-02-05 CN disclosed
CN-105106981-B Dianthranide quinones application in preparation of anti-tumor drugs 江苏省中医药研究院 2018-12-28 CN disclosed
CN-107787317-A The method that hydrogen chloride for chemical reaction is provided 科思创德国股份有限公司 2018-03-09 CN disclosed
CN-107787318-A Process for preparing polyisocyanates 科思创德国股份有限公司 2018-03-09 CN disclosed
CN-104039859-B Hydroxyl amino polymer and preparation method thereof 科思创德国股份有限公司 2017-03-01 CN disclosed
CN-106458842-A Methods for producing chemical products with operation interruptions 科思创德国股份有限公司 2017-02-22 CN disclosed
US-20160136144-A1 COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS MERZ PHARMA GMBH & CO. KGAA (DE) 2016-05-19 US disclosed
CN-1720035-A Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors MERZ PHARMA GMBH & CO KGAA (DE) 2006-01-11 CN disclosed
EP-1556019-A2 COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS Merz Pharma GmbH &amp; Co. KGaA (DE) 2005-07-27 EP disclosed
CN-1602292-A Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists MERZ PHARMA GMBH & CO KGAA (DE) 2005-03-30 CN disclosed
US-6828462-B2 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists MERZ PHARMA GMBH & CO. KGAA (DE) 2004-12-07 US disclosed
EP-1442008-A1 UNSATURATED 1-AMINO-ALKYLCYCLOHEXANE NMDA, 5HT3 AND NEURONAL NICOTINIC RECEPTOR ANTAGONISTS Merz Pharma GmbH & Co. KGaA (DE) 2004-08-04 EP disclosed
WO-2004037234-A2 COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS MERZ PHARMA GMBH & CO. KGAA (DE) 2004-05-06 WO disclosed
US-20040087658-A1 Synergistic mixture; Alzheimer's disease therapy MERZ PHARMA GMBH & CO. KGAA (DE) 2004-05-06 US disclosed
US-20030166634-A1 Unsaturated 1-Amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists MERZ PHARMA GMBH & CO. KGAA (DE) 2003-09-04 US disclosed
WO-2003040084-A1 UNSATURATED 1-AMINO-ALKYLCYCLOHEXANE NMDA, 5HT3 AND NEURONAL NICOTINIC RECEPTOR ANTAGONISTS MERZ PHARMA GMBH & CO. KGAA (DE) 2003-05-15 WO disclosed
WO-1992000981-A1 NOVEL 3-SUBSTITUTED CEPHEM COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF DAE WOONG PHARMACEUTICAL CO., LTD. (KR) 1992-01-23 WO disclosed